COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 12.68
(0.96%)
CNY 12.68
(0.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 124.8 Billion CNY | 6.4% |
| 2022 | 117.29 Billion CNY | 14.51% |
| 2021 | 102.43 Billion CNY | 20.78% |
| 2020 | 84.81 Billion CNY | 26.25% |
| 2019 | 67.17 Billion CNY | 1977.07% |
| 2018 | 3.23 Billion CNY | -5.59% |
| 2017 | 3.42 Billion CNY | -9.21% |
| 2016 | 3.77 Billion CNY | 8.31% |
| 2015 | 3.48 Billion CNY | -1.66% |
| 2014 | 3.54 Billion CNY | 19.23% |
| 2013 | 2.97 Billion CNY | 3.17% |
| 2012 | 2.88 Billion CNY | 5.65% |
| 2011 | 2.72 Billion CNY | 2.77% |
| 2010 | 2.65 Billion CNY | 43.16% |
| 2009 | 1.85 Billion CNY | 6.21% |
| 2008 | 1.74 Billion CNY | 23.04% |
| 2007 | 1.41 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 132.36 Billion CNY | 6.06% |
| 2024 Q2 | 145.25 Billion CNY | 9.74% |
| 2024 Q3 | 154.91 Billion CNY | 6.65% |
| 2023 Q2 | 129.78 Billion CNY | 2.95% |
| 2023 Q3 | 128.49 Billion CNY | -1.0% |
| 2023 FY | 124.8 Billion CNY | 6.4% |
| 2023 Q4 | 124.8 Billion CNY | -2.87% |
| 2023 Q1 | 126.06 Billion CNY | 7.47% |
| 2022 Q3 | 118.17 Billion CNY | 1.05% |
| 2022 FY | 117.29 Billion CNY | 14.51% |
| 2022 Q4 | 117.29 Billion CNY | -0.74% |
| 2022 Q2 | 116.93 Billion CNY | 1.78% |
| 2022 Q1 | 114.89 Billion CNY | 12.17% |
| 2021 FY | 102.43 Billion CNY | 20.78% |
| 2021 Q3 | 104.49 Billion CNY | 3.55% |
| 2021 Q1 | 97.09 Billion CNY | 14.48% |
| 2021 Q4 | 102.43 Billion CNY | -1.97% |
| 2021 Q2 | 100.92 Billion CNY | 3.94% |
| 2020 Q2 | 80.23 Billion CNY | 8.54% |
| 2020 Q4 | 84.81 Billion CNY | 0.72% |
| 2020 FY | 84.81 Billion CNY | 26.25% |
| 2020 Q1 | 73.92 Billion CNY | 10.04% |
| 2020 Q3 | 84.2 Billion CNY | 4.95% |
| 2019 FY | 67.17 Billion CNY | 1977.07% |
| 2019 Q3 | 68.49 Billion CNY | 9.09% |
| 2019 Q4 | 67.17 Billion CNY | -1.93% |
| 2019 Q2 | 62.79 Billion CNY | -0.92% |
| 2019 Q1 | 63.37 Billion CNY | 1859.49% |
| 2018 Q4 | 3.23 Billion CNY | -4.35% |
| 2018 Q1 | 3.49 Billion CNY | 2.03% |
| 2018 FY | 3.23 Billion CNY | -5.59% |
| 2018 Q3 | 3.38 Billion CNY | -7.61% |
| 2018 Q2 | 3.65 Billion CNY | 4.7% |
| 2017 Q2 | 3.68 Billion CNY | -2.76% |
| 2017 Q3 | 3.62 Billion CNY | -1.77% |
| 2017 Q4 | 3.42 Billion CNY | -5.45% |
| 2017 Q1 | 3.79 Billion CNY | 0.54% |
| 2017 FY | 3.42 Billion CNY | -9.21% |
| 2016 Q4 | 3.77 Billion CNY | 2.74% |
| 2016 FY | 3.77 Billion CNY | 8.31% |
| 2016 Q2 | 3.73 Billion CNY | 6.17% |
| 2016 Q3 | 3.67 Billion CNY | -1.56% |
| 2016 Q1 | 3.51 Billion CNY | 0.87% |
| 2015 Q2 | 3.43 Billion CNY | -2.25% |
| 2015 FY | 3.48 Billion CNY | -1.66% |
| 2015 Q4 | 3.48 Billion CNY | 0.74% |
| 2015 Q3 | 3.45 Billion CNY | 0.7% |
| 2015 Q1 | 3.51 Billion CNY | -0.83% |
| 2014 Q2 | 3.05 Billion CNY | 1.46% |
| 2014 Q4 | 3.54 Billion CNY | 13.62% |
| 2014 FY | 3.54 Billion CNY | 19.23% |
| 2014 Q1 | 3 Billion CNY | 1.19% |
| 2014 Q3 | 3.11 Billion CNY | 2.22% |
| 2013 Q2 | 2.64 Billion CNY | 1.11% |
| 2013 Q1 | 2.61 Billion CNY | -9.32% |
| 2013 Q4 | 2.97 Billion CNY | 2.29% |
| 2013 FY | 2.97 Billion CNY | 3.17% |
| 2013 Q3 | 2.9 Billion CNY | 10.01% |
| 2012 Q1 | 2.79 Billion CNY | 2.59% |
| 2012 Q2 | 2.86 Billion CNY | 2.55% |
| 2012 Q3 | 2.79 Billion CNY | -2.45% |
| 2012 Q4 | 2.88 Billion CNY | 2.94% |
| 2012 FY | 2.88 Billion CNY | 5.65% |
| 2011 Q1 | 2.73 Billion CNY | 3.05% |
| 2011 FY | 2.72 Billion CNY | 2.77% |
| 2011 Q4 | 2.72 Billion CNY | -1.03% |
| 2011 Q3 | 2.75 Billion CNY | -1.06% |
| 2011 Q2 | 2.78 Billion CNY | 1.85% |
| 2010 FY | 2.65 Billion CNY | 43.16% |
| 2010 Q1 | 1.89 Billion CNY | 2.05% |
| 2010 Q3 | 2.6 Billion CNY | 1.88% |
| 2010 Q4 | 2.65 Billion CNY | 1.94% |
| 2010 Q2 | 2.55 Billion CNY | 35.09% |
| 2009 Q4 | 1.85 Billion CNY | 0.0% |
| 2009 FY | 1.85 Billion CNY | 6.21% |
| 2008 FY | 1.74 Billion CNY | 23.04% |
| 2007 FY | 1.41 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 301.93 Billion CNY | 58.666% |